Tirzepatide, a dual GLP-1 and GIP receptor agonist, has become one of the most effective medications for weight loss since FDA approval in 2023
The trial showed: Tirzepatide 5 mg: 7.6 kg weight loss Tirzepatide 10 mg: 9.3 kg weight loss Tirzepatide 15 mg: 11.2 kg weight loss Semaglutide 1 mg: 5.7 kg weight loss Some articles looked at those numbers and decided "tirzepatide 10 mg is roughly equivalent to semaglutide 1 mg" because 9.3 kg is about 1.6x more than 5.7 kg, and 10 mg is 10x more than 1 mg, so the "potency ratio" is around 6:1
It has a Discord community with a health-coaching channel, but its not a structured program
Individual results vary depending on starting weight, dose, lifestyle, and duration of treatment
Finally, you might experience improved focus, memory, and overall mental clarity during your everyday life
Real-world evidence (Nature, 2023) A survey of 153 adults with obesity who were already taking semaglutide or tirzepatide found they reported a 73% reduction in weekly alcohol consumption, and their likelihood of binge-drinking dropped by about 80% compared to similar people not on medication